Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-DCFPyL PET/CT in HER2-negative, AR-Positive Metastatic Breast Cancer
NCT04573231Phase 2Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- May 2021
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of piflufolastat f 18 in breast cancer, sponsored by University of Wisconsin–Madison. Started May 2021; status: completed.
02
Drugs
piflufolastat f 18
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04573231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04573231.